US Patent Issued to The University of British Columbia on Oct. 28 for "Monbretin a (MbA) synthesis using a heterologous nucleic acid(s) encoding a MbA pathway enzyme" (Canadian Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,714, issued on Oct. 28, was assigned to The University of British Columbia (Vancouver, Canada).

"Monbretin a (MbA) synthesis using a heterologous nucleic acid(s) encoding a MbA pathway enzyme" was invented by Carl Joerg Bohlmann (Vancouver, Canada), Sandra Irmisch (Vancouver, Canada) and Seohyun Jo (Vancouver, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are transgenic organisms, such as plants and plant parts, cells, and related compositions and methods for producing and monitoring the genotype for enhanced production of montbretin A and/or its precursors. For example, provided is a transgenic organism comprising at least one hete...